Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Social Anxiety Disorder Linked to High Serotonin Levels, Throwing Treatment with SSRIs into Serious ...

A short-term Borrelia burgdorferi infection model identifies tissue tropisms and bloodstream surviva...

Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases

Promoting Optimal Nutrition with Digestive Enzymes

Immune response to a flu vaccine yields new insights into narcolepsy

Omega-3 supplements and antioxidants may help with preclinical Alzheimer's disease

Children with Lyme Disease

Health Benefits of Ginseng

7-Keto DHEA The Fat-Burning Metabolite of DHEA

Intestinal Pseudoobstruction Caused by Chronic Lyme Neuroborreliosis. A Case Report

 
Print Page
Email Article

Abstract: Treatment of Fibromyalgia with Antidepressants: A Meta-Analysis

  [ 46 votes ]   [ Discuss This Article ]
By P.G. O'Malley, E. Balden, G. Tomkins, J. Santoro, K. Kroenke, J.L. Jackson • www.ProHealth.com • November 7, 2001



Competing interests: None declared

Funding: MacArthur Foundation Initiative on Depression in Primary Care. This digest and commentary appeared in Evidence-Based Medicine, 2001; 6:77

DATA SOURCES
Studies in any language were identified by searching MEDLINE (1966 to June 1999), PsycLIT (1974-1998), and EMBASE/Excerpta Medica (1974-1998) with the terms fibromyalgia, fibrositis, and fibromyositis combined with various terms for antidepressive agents (including specific drug names); the Cochrane Library Clinical Trials Registry and Database of Systematic Reviews; Federal Research in Progress to identify unpublished trials; and bibliographies of reviewed articles.

STUDY SELECTION
Studies were selected if they were randomized, placebo-controlled trials with at least 1 group receiving an antidepressant drug and if they reported measurable outcomes.

DATA EXTRACTION
Data were extracted on setting; country; dose, duration, and follow-up of treatment; number of participants and demographics; assessment of comorbid disease; follow-up losses (i.e., unavailable for follow-up); adverse effects; and outcomes. Methodologic quality of individual trials was assessed using the Jadad scale.

MAIN RESULTS
We included 13 trials (mean sample size, 54; mean duration, 8.1 weeks) in the analysis. Mean quality score for the Jadad scale was 5.6 of a maximum of 8. Nine studies did not give the method of randomization, 7 had no intention-to-treat analysis, 3 inadequately assured blinding effectiveness, 5 did not assess adverse effects, and 6 had lower than 20% loss to follow-up. Trials assessed the efficacy of 3 classes of antidepressant drugs: tricyclic antidepressants (8 trials of amitriptyline hydrochloride, 1 of clomipramine hydrochloride, and 1 of maprotiline hydrochloride), S-adenosyl-1-methionine (2 trials), and selective serotonin reuptake inhibitors (2 of fluoxetine hydrochloride and 1 of citalopram hydrobromide).

Meta-analysis was done using a random-effects model. Meta-analysis of dichotomous outcome data (10 trials) showed that patients who received antidepressants had more symptom improvement than those who received placebo (odds ratio, 4.2 [95% confidence interval (CI), 2.6-6.8]; number needed to treat, 4 [95% CI, 2.9-6.3]). Meta-analysis of continuous outcome data showed that antidepressant drugs were associated with improvements in fatigue scores (8 trials, 0.39 SD unit improvement [95% CI, 0.11-0.66]), sleep scores (8 trials, 0.49 SD unit improvement [95% CI, 0.3-0.69]), pain scores (10 trials, 0.52 SD unit improvement [95% CI, 0.21-0.81]), and overall well-being (7 trials, 0.49 SD unit improvement [95% CI, 0.18-0.80]) but not in the number of trigger points.

CONCLUSION
Antidepressant drugs improve overall symptoms and individual symptoms of fatigue, sleep, and pain in patients with fibromyalgia.











Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Nutritional Supplement Orders

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS Diagnosis
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE  |  PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing